Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake

Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake
The logo of Swiss drugmaker Roche at its headquarters in Basel, Switzerland, on Jan. 30, 2020. Arnd Wiegmann/Reuters
Reuters
Updated:

ZURICH—Roche shareholders voted overwhelmingly on Friday to support the $20.7 billion deal to buy Novartis’s nearly one third voting stake, the Swiss drugmaker said.

Roche held an extraordinary general meeting to settle matters related to its plan to disentangle the two pharma companies, both based in Basel, who had been linked by the investment for two decades.